Lung Cancer Screening Software Market
Lung Cancer Screening Software Market - Global Industry Assessment & Forecast
#
Pages:
197
2023
Jul - 2024
VMR-2542
Segments Covered
By
Mode of Delivery Cloud Based Solutions, On-Premise Solutions, Web Based Solutions
-
By
Product Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management, Audit Log Tracking
-
By
Type Computer-Assisted Screening, Traditional Screening
-
By
Application Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)
-
By
Platform Standalone, Integrated
-
By
Purchase Mode Institutional, Individual
-
By
End User Oncology Centers, Hospitals, Ambulatory Surgical Centers, Other End Users
-
By
Distribution Channel Direct Tender, Third Party Distributors
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 30.2 Million |
 Revenue 2032:
|
USD 146.32 Million |
 Revenue CAGR
(2024 - 2032): |
19.2% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2018 to 2022 |
| 3. | Forecast Data | 2024 to 2032 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
FAQ
Frequently Asked Question
What is the global demand for Lung Cancer Screening Software in terms of revenue?
-
The global Lung Cancer Screening Software valued at USD 30.2 Million in 2023 and is expected to reach USD 146.32 Million in 2032 growing at a CAGR of 19.2%.
Which are the prominent players in the market?
-
The prominent players in the market are GE Healthcare (U.S.), IBM Watson Health (U.S.), Siemens Healthineers (Germany), Optellum (UK), Philips Healthcare (Netherlands), McKesson Corp. (U.S.), Koninklijke Philips N.V. (Netherlands), Varian Medical Systems (U.S.), Thermo Fisher Scientific Inc. (U.S.), Hologic Inc. (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 19.2% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Lung Cancer Screening Software include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Lung Cancer Screening Software in 2023.
